PrecisionMed Conference 2023

PrecisionMed Conference is an unrivalled opportunity for healthcare providers, researchers, public sector buyers and influencers and others from across this eco-system within the Gulf Cooperative Council, to attend as delegates and catch up on latest developments, opportunities and outcomes within this dynamic area of disease prevention, diagnostics and treatment.

Global thought and knowledge leaders at the 2022 edition

Dame Professor Sue Hill

Chief Scientific Officer, England

Exclusive Pre-recorded Session

Min S. Park, PhD

CSO, Sanimed International, Abu Dhabi

H.E Dr. Maryam Matar

Founder and Chairperson, UAE Genetic Diseases Association (UAEGDA)

Robert C. Green, MD, MPH

Professor of Medicine, Harvard Medical School, Geneticist, Mass General Brigham, Broad Institute; Director, Genomes2People Research Program

Ahmad Abou Tayoun, PhD, FACMG

Director, Genomics Center at Al Jalila Children’s; Associate
Professor of Genetics, Mohammed Bin Rashid University of Medicine and Health Sciences

Heidi Rehm, PhD

Chief Genomics Officer, Department of Medicine, MGH; Co-Director, Medical and Population Genetics, Broad Institute

Exclusive Pre-recorded Session

Joanne Hackett

Head of Genomic and Precision Medicine, IQVIA

Renyan Lou

Head of Genomic and Precision Medicine, IQVIA

Dr Fatma Alhashimi, PhD

Director of Sheikh Zayed Genetic Research Centre

Khalid Fakhro, PhD

Chief Research Officer,
Sidra Medicine

Fatma Al Jasmi, MBBS, FRCPC, FCCMG

Chair of Genetic & Genomic Department, College of Medicine & Health Science, UAE University

Dr Marjane Le Bagousse, MD, MSc, EM

Medical Director,
Veracyte Immuno-Oncology

Dr Younes Mokrab

Principal investigator, Head of Medical and Population Genomics Lab, Sidra Medicine

Hinda Daggag, PhD

Corporate Head of Genetic Projects, SEHA

Aaron Han, MD, PhD

Consultant, Pathology, COVID Lab, Infection Control, King’s College Hospital London – UAE

Lova Satyanarayana Matsa, PhD

Scientific Director, Igenomix

Sarah Chahine

Emerging Markets Leader for Clinical Sequencing Division, Thermo Fisher Scientific

Shoaib Al Zadjali, PhD

Head of Research Laboratories, Sultan Qaboos Comprehensive Cancer Care & Research Centre (SQCCCRC)

Dr. Ihsan Almarzooqi

Co-Founder & Managing Director, Glucare

Byoungkwon Kim M.D.

Consultant pathologist in Department of Pathology, Sheikh Khalifa Specialty Hospital (SKSH), United Arab Emirates

Dr Susanna Akiki, PhD DipRCPath (UK)

Consultant Clinical Scientist, Head of Haemato Oncology, Diagnostic Genomic Division, Hamad Medical Corporation, Qatar

Dr. Shakir Bahzad, MD, FRCPC

Head of Molecular Pathology Lab, Kuwait Cancer Control Center

Dr Bernice Lo

Principal Investigator, Precision Medicine Research Branch, Sidra Medicine

Abdul Wahid Khan

BIS Research

George P. Patrinos

Professor, University of Patras, Greece; Adjunct Professor; United Arab Emirates University, Department of Genetics and Genomics Al-Ain, UAE

Dr. Samih Alqawlaq

Senior Clinical Sales Specialist, Illumina

Mohamed Nagy, Pharm, RPh, MS

Head of Personalized Medication Management Unit, Children’s Cancer Hospital, Egypt

Stefan Nierkens, PhD

Associate Professor and Medical Immunologist, Center for Translational Immunology, University Medica Center Utrecht

Richard O Kennedy,
B.Sc., Ph.D., C. Biol., FRSB., F.I.Biol.I., Dip. F.S., Dip. C.S., Dip. Computing, MRIA

Vice-President for Research, Hamad Bin Khalifa University; and Vice-President for Research, Development and Innovation (RDI), Qatar Foundation

Shameer Khader, PhD

Senior Director (Machine Learning Research)

Dr. Stefan Griesbach

Head of Sales,
CeGaT GmbH

Toby Huang, BSc, MSc

BD Director, APAC & ME
MGI Tech Co Ltd

Ayman El-Hattab, MD

Consultant & Scientific Advisory Board member for Middle East, Igenomix

Houari Abdesselem, PhD

Manager, Proteomics Core Facility, Qatar Biomedical Research Institute, Hamad Bin Khalifa University

José Luis Costa

Global Director of Scientific Affairs of the Clinical NGS and Oncology Division,
Thermo Fisher Scientific

Peeter Padrik, MD, PhD

Founder and CEO of Antegenes; Associate Professor of Oncology at University of Tartu, Estonia; Medical Oncologist, Tartu University Hospital, Estonia

M. Walid Qoronfleh, PhD, MBA

Executive Director, Q3CG Research Institute (QRI)